Jinyu Bio-Technology CoSHSE:600201 +1.36%68 Gross Margin % is 53.48% as of Mar. 2026, which is 13% below its 10-year median of 61.74. GuruFocus rates SHSE:600201 with a GF Score™ of 68/100 and a GF Value™ of ¥8.23 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 733 Biotechnology companies, Jinyu Bio-Technology Co ranks worse than 57.71% on this metric.
SHSE:600201's Gross Margin % is ranked worse than 57.71% of 733
companies
in the Biotechnology industry
Industry Median: 60.9
vs SHSE:600201: 53.27
Jinyu Bio-Technology Co had a gross margin of 53.48% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Jinyu Bio-Technology Co was -3.00% per year.
Jinyu Bio-Technology Co (SHSE:600201) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Jinyu Bio-Technology Co had a gross margin of 53.48% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Jinyu Bio-Technology Co Gross Margin % Related Terms
Jinyu Bio-Technology Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600201 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Jinyu Bio-Technology Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinyu Bio-Technology Co Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Jinyu Bio-Technology Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Jinyu Bio-Technology Co (SHSE:600201) has a Gross Margin % of 53.48% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Jinyu Bio-Technology Co and its competitors. This is 13% below median its historical median of 61.74. Over the past decade, Jinyu Bio-Technology Co's Gross Margin % has ranged from 53.27 to 79.37. According to the industry distribution chart, Jinyu Bio-Technology Co ranks #423 out of 733 companies in the Biotechnology industry, placing it in the top 57.7%.
Is Jinyu Bio-Technology Co's Gross Margin % too high?
Jinyu Bio-Technology Co's current Gross Margin % of 53.48% is 13% below median its 10-year median of 61.74. Over the past 10 years, this metric has ranged from a low of 53.27 to a high of 79.37. The Biotechnology industry median Gross Margin % is 60.90. Jinyu Bio-Technology Co's value of 53.48% is 12.2% below this industry median. Based on the distribution chart, Jinyu Bio-Technology Co ranks #423 out of 733 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Jinyu Bio-Technology Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jinyu Bio-Technology Co ranks #423 out of 733 companies for Gross Margin %. This places Jinyu Bio-Technology Co in the lower half of its industry. The industry median Gross Margin % is 60.90. Jinyu Bio-Technology Co's value of 53.48% is 12.2% below this benchmark. Historically, Jinyu Bio-Technology Co's own Gross Margin % has ranged from 53.27 to 79.37 over the past decade. While the company's 10-year median is 61.74 vs. the industry median of 60.90, Jinyu Bio-Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinyu Bio-Technology Co's current Gross Margin % of 53.48% is 12.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Jinyu Bio-Technology Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinyu Bio-Technology Co's current Gross Margin % is 53.48%, which is 13% below median its own 10-year median of 61.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.23, compared to a current price of ¥11.96 — trading 45.3% above its estimated fair value. The current Gross Margin % is 53.48%, which is 13% below median its 10-year median of 61.74 and 12.2% below the Biotechnology industry median of 60.90. Jinyu Bio-Technology Co's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current Gross Margin % is 53.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥11.96 is trading 45.3% above its estimated GF Value™ of ¥8.23.
GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.
Key valuation signals for SHSE:600201:
Gross Margin %: 53.48% (13% below median its 10-year median of 61.74)
GF Value™: ¥8.23 vs. price of ¥11.96 (45.3% above fair value)
Industry Position: 12.2% below the Biotechnology median (#423 of 733)
No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
68GF Score
Get the complete analysis for SHSE:600201
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600201 has been successfully added to your 
